VTV240816P150000
- 0.55
- 0.000.00%
Vanguard Value ETF Newsroom
Procter & Gamble Price Target Cut to $179.00/Share From $181.00 by JP Morgan
Merck Price Target Cut to $145.00/Share From $150.00 by B of A Securities
Merck & Co Analyst Ratings
UBS Maintains Buy on Merck & Co, Lowers Price Target to $142
Procter & Gamble Analyst Ratings
HSBC Adjusts Price Target on AbbVie to $215 From $185
Morgan Stanley Maintains Procter & Gamble(PG.US) With Buy Rating, Maintains Target Price $174
Evercore Maintains Procter & Gamble(PG.US) With Buy Rating, Cuts Target Price to $180
Morgan Stanley Maintains Merck & Co(MRK.US) With Hold Rating, Cuts Target Price to $130
Evercore Maintains Merck & Co(MRK.US) With Buy Rating
BofA Securities Maintains Procter & Gamble(PG.US) With Buy Rating
BofA Securities Initiates Merck & Co(MRK.US) With Buy Rating
A Quick Look at Today's Ratings for Procter & Gamble(PG.US), With a Forecast Between $164 to $189
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $125 to $150
Merck & Company (MRK) Gets a Hold From Morgan Stanley
Morgan Stanley Remains a Buy on Procter & Gamble (PG)
Buy Rating on Merck & Co. Amid Temporary Setbacks and Strong Growth Outlook
Analysts Offer Insights on Consumer Goods Companies: Procter & Gamble (PG), Sysco (SYY) and Mondelez International (MDLZ)
Wells Fargo Adjusts Price Target on Merck & Co. to $125 From $140, Maintains Equalweight Rating
Maintaining Buy Rating: Procter & Gamble's Setbacks Deemed Temporary Amidst Strong Growth Prospects